A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients

[1]  B. Han,et al.  Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer , 2011, Cancer Immunology, Immunotherapy.

[2]  Qiang Deng,et al.  Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges. , 2011, Journal of hepatology.

[3]  S. Gadgeel.  The Optimal Chemotherapy for Stage III Non–Small Cell Lung Cancer Patients , 2011, Current oncology reports.

[4]  G. Giaccone,et al.  Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic reality. , 2010, Clinical Lung Cancer.

[5]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.

[6]  B. Clausen,et al.  Dual therapeutic efficacy of vinblastine as a unique chemotherapeutic agent capable of inducing dendritic cell maturation. , 2009, Cancer research.

[7]  F. Farzaneh,et al.  Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs , 2009, Journal of Translational Medicine.

[8]  H. Mellstedt,et al.  The future of cancer vaccines for non-small-cell lung cancer: ongoing trials. , 2008, Clinical lung cancer.

[9]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  J. Gulley,et al.  Therapeutic vaccines for prostate cancer. , 2006, The oncologist.

[11]  P. Lollini,et al.  Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti‐OX40 and anti‐4‐1BB monoclonal antibodies induces T cell–mediated protective immunity in Her‐2/neu transgenic mice , 2005, International journal of cancer.

[12]  J. Schlom,et al.  Induction of Higher-Avidity Human CTLs by Vector-Mediated Enhanced Costimulation of Antigen-Presenting Cells , 2005, Clinical Cancer Research.

[13]  R. Negrin,et al.  A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  P. Brossart,et al.  Cellular Immunotherapy with Dendritic Cells in Cancer: Current Status , 2004, Stem cells.

[15]  T. Sauerbruch,et al.  Interactions Between Dendritic Cells and Cytokine-Induced Killer Cells Lead to an Activation of Both Populations , 2001, Journal of immunotherapy.

[16]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[17]  R. Negrin,et al.  Cellular immunotherapy and autologous transplantation for hematologic malignancy , 1997, Immunological reviews.

[18]  X. Hao,et al.  Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients , 2012, Cancer Immunology, Immunotherapy.

[19]  Ying Han,et al.  Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. , 2009, Cytotherapy.

[20]  Kanji Takahashi,et al.  Impaired function of circulating dendritic cells in patients with pancreatic cancer. , 2005, Clinical immunology.

[21]  D. Tyler,et al.  Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity. , 2004, The Journal of surgical research.

[22]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 1995. , 2002, European journal of cancer.

[23]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.